Compass Therapeutics (CMPX) Equity Average (2018 - 2026)
Compass Therapeutics recorded quarterly Equity Average of $191.6 million in Q1 2026, down 5.69% quarter-over-quarter from $203.2 million in Q4 2025, and up 62.74% year-over-year from $117.8 million in Q1 2025.
Compass Therapeutics' Equity Average history runs 9 years deep, the most recent figure standing at $191.6 million for Q1 2026.
- In Q1 2026, Equity Average rose 62.74% year-over-year to $191.6 million; the TTM figure through Mar 2026 stood at $191.6 million (up 62.74% YoY), while the FY2025 annual figure was $161.0 million, up 17.63% from the prior year.
- Equity Average came in at $191.6 million for Q1 2026 at Compass Therapeutics, down from $203.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $203.2 million in Q4 2025 to a low of $101.7 million in Q2 2025.
- A 5-year average of $150.1 million and a median of $151.4 million in 2025 frame the typical range for Equity Average.
- Across the five-year window, Equity Average surged 273.99% in 2022 and slumped 32.88% in 2025, its largest moves.
- Compass Therapeutics' Equity Average stood at $148.9 million in 2022, then advanced by 3.64% to $154.3 million in 2023, then fell by 14.57% to $131.8 million in 2024, then jumped by 54.16% to $203.2 million in 2025, then fell by 5.69% to $191.6 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $191.6 million, $203.2 million, and $151.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 191.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191.63 Mn |
| Dec 31, 2025 | 203.20 Mn |
| Sep 30, 2025 | 151.41 Mn |
| Jun 30, 2025 | 101.74 Mn |
| Mar 31, 2025 | 117.76 Mn |
| Dec 31, 2024 | 131.82 Mn |
| Sep 30, 2024 | 142.25 Mn |
| Jun 30, 2024 | 151.58 Mn |
| Mar 31, 2024 | 152.80 Mn |
| Dec 31, 2023 | 154.29 Mn |
| Sep 30, 2023 | 164.17 Mn |
| Jun 30, 2023 | 171.78 Mn |
| Mar 31, 2023 | 178.45 Mn |
| Dec 31, 2022 | 148.88 Mn |
| Sep 30, 2022 | 121.52 Mn |
| Jun 30, 2022 | 130.71 Mn |
| Mar 31, 2022 | 137.28 Mn |
| Dec 31, 2021 | 81.98 Mn |
| Mar 31, 2021 | 36.71 Mn |
| Dec 31, 2020 | 43.62 Mn |
| Sep 30, 2020 | 50.27 Mn |
| Jun 30, 2020 | -35.75 Mn |
| Mar 31, 2020 | -56.75 Mn |
| Dec 31, 2019 | -50.48 Mn |
| Sep 30, 2019 | -108.07 Mn |
| Jun 30, 2019 | -99.60 Mn |
| Mar 31, 2019 | -90.03 Mn |
| Dec 31, 2018 | -42.41 Mn |
| Sep 30, 2018 | -47,304.00 |
| Jun 30, 2018 | -38,789.00 |